Primary AML samples taken at time of diagnosis from two different datasets express significantly higher transcript levels of NKG2D ligands MICA/MICB, ULBP1, and ULBP2 compared to healthy PBMC control (Figures 4A–C). The gene discussed is ULBP1; the disease is acute myeloid leukemia.